RedHill Biopharma Ltd. reports

Company location
Tel Aviv, Israel
RedHill Biopharma Ltd. has filed 1,017 SEC EDGAR filings since 01 Oct 2012

SEC filing history

Showing 226-250 of 1,000 matching filings.

Per page
25
Current page
10
6-K File 001-35773

6-K

Filing date
28 Mar 2023
Reporting date
28 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-268713

424B3

Filing date
22 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
21 Mar 2023
Reporting date
21 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
17 Mar 2023
Reporting date
16 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
13 Mar 2023
Reporting date
13 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
09 Mar 2023
Reporting date
09 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
06 Mar 2023
Reporting date
06 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
28 Feb 2023
Reporting date
28 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
16 Feb 2023
Reporting date
16 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
15 Feb 2023
Reporting date
15 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
06 Feb 2023
Reporting date
06 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
26 Jan 2023
Reporting date
26 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
25 Jan 2023
Reporting date
25 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
24 Jan 2023
Reporting date
24 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87280

REDHILL BIOPHARMA LTD.

Filing date
13 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87280

SABBY 13G RDHL 1.04.23

Filing date
04 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
03 Jan 2023
Reporting date
03 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K/A File 001-35773

6-K/A

Filing date
27 Dec 2022
Reporting date
27 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
20 Dec 2022
Reporting date
20 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
12 Dec 2022
Reporting date
12 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
F-6EF File 333-268713

FORM F-6EF

Filing date
08 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
06 Dec 2022
Reporting date
06 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-258259

424B5

Filing date
06 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
05 Dec 2022
Reporting date
05 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
05 Dec 2022
Reporting date
05 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .